PCM Trials Acquires Netherlands-Based Clinical Trial Service

PCM Trials, a Denver, USA-based provider of mobile research nurses for decentralized clinical trials (DCTs), announced the acquisition of Clinical Trial Service (CTS). The Losser, Netherlands-based private clinical research company has been a long-standing partner of PCM Trials and has more than 30 years of experience in managing and staffing global clinical trials with GCP-trained mobile research nurses for DCTs. The acquisition, which is effective immediately, expands PCM Trials’ already extensive global footprint.

CTS was founded in 1993 in Losser, Netherlands, and quickly became a preferred provider of mobile research nurses for some of the biggest names in the pharmaceutical industry. The organization has a network of over 40 mobile nurse partners that it manages as part of its robust network of local country nursing providers, which provide quality solutions by highly screened, selected, managed, and trained research nurses in more than 80 countries. In addition to handling staffing needs for mobile trials, CTS also manages various logistics functions to ensure that trial investigational products and necessary lab materials are delivered on time to the right patients and administered by nurses with protocol-specific training and experience.

PCM Trials has completed numerous global trials since its founding in 2008 and has the capability to deliver mobile visits in more than 80 countries. According to Austin, the acquisition of CTS represents one more step taken by PCM Trials to make available the most direct nursing model on a global scale. To date, PCM Trials has effectively served more than 150 sponsors and more than 300 protocols. Many of these trials were completed as a result of PCM’s partnership with CTS. Now, as one company, PCM Trials has eliminated an administrative layer to create an even more direct relationship between sponsors and mobile research nurses. The result, according to Austin, will be a simplified contracting process for customers, improved communications for study teams, faster turnaround, greater consistency, and higher quality research data.

Bruggink and her entire CTS team will remain with the company to help ensure a smooth transition and continue all ongoing and future clinical trials for clinical operations and DCTs. CTS will continue to operate its European office and logistics center in Losser, the Netherlands under the CTS brand and with its current employees. CTS, as part of PCM Trials, will continue to serve customers in all sectors such as Sponsors, CROs, and mobile research nursing vendors in various mobile visit models.

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special
offers from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!

  • <<
  • >>

Join the Discussion